A Study to Assess the Efficacy, Safety and Tolerability of Different Doses of AZD0780 in Patients With Dyslipidemia

PHASE2CompletedINTERVENTIONAL
Enrollment

428

Participants

Timeline

Start Date

January 19, 2024

Primary Completion Date

September 30, 2024

Study Completion Date

September 30, 2024

Conditions
Dyslipidemia
Interventions
DRUG

AZD0780

AZD0780 administered orally, once daily for 12 weeks

DRUG

Placebo

Placebo administered orally, once daily for 12 weeks

Trial Locations (55)

1027

Research Site, Budapest

2650

Research Site, Hvidovre

4032

Research Site, Debrecen

5700

Research Site, Svendborg

5900

Research Site, Orosháza

7400

Research Site, Herning

7624

Research Site, Pécs

8200

Research Site, Aarhus

8800

Research Site, Viborg

12553

Research Site, New Windsor

14004

Research Site, Córdoba

15006

Research Site, A Coruña

15405

Research Site, Ferrol

15706

Research Site, Santiago(A Coruña)

27408

Research Site, Greensboro

32216

Research Site, Jacksonville

33012

Research Site, Hialeah

33434

Research Site, Boca Raton

34452

Research Site, Inverness

35801

Research Site, Huntsville

40213

Research Site, Louisville

41004

Research Site, Seville

41013

Research Site, Seville

41071

Research Site, Seville

46260

Research Site, Indianapolis

58104

Research Site, Fargo

68601

Research Site, Uherské Hradiště

78666

Research Site, San Marcos

92262

Research Site, Palm Springs

92704

Research Site, Santa Ana

95648

Research Site, Lincoln

L4N 7L3

Research Site, Barrie

L6S 0C6

Research Site, Brampton

N1R 6V6

Research Site, Cambridge

L4K 4M2

Research Site, Concord

N1H 1B1

Research Site, Guelph

M6G 1M2

Research Site, Toronto

256 01

Research Site, Benešov

250 01

Research Site, Brandýs nad Labem

603 00

Research Site, Brno

440 01

Research Site, Louny

547 01

Research Site, Náchod

150 00

Research Site, Prague

261 01

Research Site, Příbram

415 01

Research Site, Teplice

103-0027

Research Site, Chūōku

173-0004

Research Site, Itabashi-ku

831 03

Research Site, Bratislava

977 01

Research Site, Brezno

984 01

Research Site, Lučenec

080 01

Research Site, Prešov

048 01

Research Site, Rožňava

08901

Research Site, Svidník

075 01

Research Site, Trebišov

08041

Research Site, Barcelona

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY